35468-69-0

Basic information

• Product Name: 2-hydroxy-2-phenylbutanoic acid
• Synonyms: 2-hydroxy-2-phenylbutanoic acid
• CAS NO: 35468-69-0
• Molecular Formula: C₁₀H₁₂O₃
• Molecular Weight: 180.2005
• Mol File: 35468-69-0.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 337.8°Cat760mmHg
• Flash Point: 172.3°C
• Appearance: /
• Density: 1.215g/cm³
• Vapor Pressure: 4E-05mmHg at 25°C
• Refractive Index: 1.557
• CAS DataBase Reference: 2-hydroxy-2-phenylbutanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-hydroxy-2-phenylbutanoic acid(35468-69-0)
• EPA Substance Registry System: 2-hydroxy-2-phenylbutanoic acid(35468-69-0)

Safety Data

• Hazardous Substances Data: 35468-69-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C10H12O3/c1-2-10(13,9(11)12)8-6-4-3-5-7-8/h3-7,13H,2H2,1H3,(H,11,12)

Upstream product

• 2406-21-5 2-hydroxy-2-phenyl-butyric acid ethyl ester 
• 151-50-8 potassium cyanide 
• 93-55-0 1-phenyl-propan-1-one 
• 925-90-6 ethylmagnesium bromide 
• 611-73-4 Benzoylformic acid 
• 90-27-7 2-Phenylbutyric acid 
• 52839-87-9 HEPA 
• 111035-95-1 2-hydroxy-2-ethyl-2-phenylacetonitrile 
• 1603-79-8 phenylglyoxylic acid ethyl ester 
• 600-18-0 2-Oxobutyric acid 
• 100-58-3 phenylmagnesium bromide 

Downstream Products

• 76142-48-8 2-hydroxy-2-phenylbutyric acid methyl ester 
• 20432-26-2 2-phenyl-trans-crotonic acid 
• 3127-67-1 2-phenyl-cis-crotonic acid 
• 24256-91-5 (S)-2-hydroxy-2-phenylbutanoic acid 
• 81340-08-1 9-O-<(+/-)-2-hydroxy-2-phenylbutyryl>retronecine 
• 2406-21-5 2-hydroxy-2-phenyl-butyric acid ethyl ester 
• 81340-07-0 9-O-<(+/-)-2-hydroxy-2-phenylbutyryl>retronecine N-oxide 
• 52839-87-9 HEPA 
• 27739-61-3 2-hydroxy-1,2-diphenylbutan-1-one 
• 80565-32-8 2-[4-(4-chlorophenyl)phenyl]-5-ethyl-5-phenyl-1,3-dioxolan-4-one 

Relevant articles and documents

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to methods for making compounds useful in the treatment of Hepatitis C virus (HCV) infection.

HEPATITIS C VIRUS INHIBITORS

This disclosure concerns novel compounds of Formula (I) or Formula (II) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.